In the BIOGEAS Registry, demyelination was estimated to occur in 0.03–0.2% of patients, most frequently in those with RA/JIA , IBD, & in patients exposed to etanercept and #infliximab
In A review of 39,933 patients exposed to biologics found CNS #demyelinatingdiseases in 13 patients (0.03%)

New study highlights key age-related differences in #NMOSD outcomes. Patients with late-onset NMOSD had poorer functional prognosis, especially if AQP4-ab(+).

Read more: www.sciencedirect.com/science/arti...

#Neuroimmunology #MultipleSclerosis #DemyelinatingDiseases #NeurologyResearch